Loading...
NeueHealth, Inc.
NEUE•NYSE
Healthcare
Medical - Equipment & Services
$6.85
$0.00(0.00%)
NeueHealth, Inc. (NEUE) Financial Performance & Statements
Review NeueHealth, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-19.31%
↓ 19.31%
Operating Income Growth
82.31%
↑ 82.31%
Net Income Growth
88.30%
↑ 88.30%
Operating Cash Flow Growth
95.48%
↑ 95.48%
Operating Margin
-9.00%
↓ 9.00%
Gross Margin
22.17%
↑ 22.17%
Net Profit Margin
-15.83%
↓ 15.83%
ROE
21.99%
↑ 21.99%
ROIC
48.49%
↑ 48.49%
NeueHealth, Inc. (NEUE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for NeueHealth, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $215.79M | $232.64M | $232.93M | $225.99M |
| Cost of Revenue | $160.89M | $184.89M | $182.69M | $177.68M |
| Gross Profit | $54.89M | $47.75M | $50.24M | $48.31M |
| Gross Profit Ratio | $0.25 | $0.21 | $0.22 | $0.21 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $84.83M | $60.32M | $66.20M |
| Operating Expenses | $213.13M | $77.16M | $67.58M | $74.21M |
| Total Costs & Expenses | $374.02M | $262.06M | $250.28M | -$251.89M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $6.64M | $6.25M | $5.41M | $4.11M |
| Depreciation & Amortization | $3.56M | $3.60M | $3.50M | $3.98M |
| EBITDA | -$14.57M | -$36.90M | -$14.30M | -$31.36M |
| EBITDA Ratio | -$0.07 | -$0.16 | -$0.06 | -$0.14 |
| Operating Income | $2.66M | -$29.42M | -$17.34M | -$37.55M |
| Operating Income Ratio | $0.01 | -$0.13 | -$0.07 | -$0.17 |
| Other Income/Expenses (Net) | -$3.99M | -$13.73M | -$5.87M | -$13.55M |
| Income Before Tax | -$1.33M | -$43.15M | -$23.21M | -$39.45M |
| Income Before Tax Ratio | -$0.006 | -$0.19 | -$0.10 | -$0.17 |
| Income Tax Expense | $111000.00 | -$672000.00 | $2.79M | -$187000.00 |
| Net Income | -$24.88M | -$2.72M | -$57.41M | -$58.63M |
| Net Income Ratio | -$0.12 | -$0.01 | -$0.25 | -$0.26 |
| EPS | -$2.90 | $20.71 | -$8.51 | -$7.10 |
| Diluted EPS | -$2.90 | $20.71 | -$8.51 | -$7.10 |
| Weighted Avg Shares Outstanding | $8.57M | $8.23M | $8.28M | $8.25M |
| Weighted Avg Shares Outstanding (Diluted) | $8.57M | $8.23M | $8.28M | $8.25M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan